ApolloMed and USC Launch Hospitalist Leadership Fellowship Program

News provided by

Mar 30, 2015, 09:00 ET

GLENDALE, Calif., March 30, 2015 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-QB: AMEH), an integrated physician-centric healthcare delivery company, and the Keck School of Medicine of the University of Southern California (USC) Internal Medicine Residency Program today announced the launch of the USC Hospitalist Leadership Fellowship Program at ApolloMed.

The Fellowship will be an intensive one-year training and educational program designed to provide internal medicine graduates with experience in all aspects of hospitalist medicine healthcare delivery and will provide trainees with the foundation to become the next generation of hospitalist leaders. The curriculum will involve 50% clinical training and 50% non-clinical training, and will include education on patient safety, quality improvement, utilization management, care coordination, reducing readmissions, hospital and managed care financial metrics and the business side of hospital medicine.

"We are very pleased to join the Keck School of Medicine of USC in developing this much needed program," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. "Regardless of who is in the White House or which party controls the Congress, healthcare is transforming rapidly, with two-thirds of payments expected to be based on value-based models within the next three years. This will require strong physician leaders to not only improve the quality of patient care but also the efficiency of the healthcare delivery system."

Hospitalists are responsible primarily for caring for inpatients admitted through the clinic or emergency department. The hospitalist model has evolved into a split model in which outpatient physicians continue seeing patients in the clinic with the hospitalist taking over when the patient needs to be admitted. With the advent of the Affordable Care Act, the hospitalist role can shorten the length of a patient's stay and improve quality and safety while reducing costs.

"This is a unique opportunity for anyone interested in the future of hospital medicine," stated Michael Karp, M.D., Interim Chief for the Division of Geriatrics, Hospital, Palliative, and General Internal Medicine at USC. "This fellowship not only allows for medical training at an outstanding institution, but is crafted in a way that allows our fellows to learn key concepts regarding the delivery of health care including quality, safety, cost-effectiveness, and resource management. This will likely become a model that others will follow in order to prepare the future leaders in the field of hospital medicine."

The fellowship is designed to be a one-year program. Fellows receive advanced training in hospital medicine, as well as dedicated training in quality metrics, safety measures, utilization review, billing, and transitions of care. Keck School of Medicine of USC faculty in conjunction with the ApolloMed team conduct the training.

Vickie Wu, M.D., who will lead USC's involvement as the Fellowship Program Director stated, "Hospital medicine is a rapidly growing field, and the one-year Hospital Medicine Fellowship is designed to integrate clinical experience with the development of the skill set necessary for hospital operations and quality improvement. Our goal is to train physicians to become future leaders of hospital medicine."

About Apollo Medical Holdings, Inc. (ApolloMed)

ApolloMed is a leading integrated physician-centric healthcare delivery company committed to providing exceptional multi-disciplinary care in the communities it serves. ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated healthcare delivery platform comprised of six affiliated and complementary physician groups: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group (Independent Physician Association), AKM Medical Group (IPA), ApolloMed Care Clinics and Apollo Palliative Services. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care. For more information, please visit www.apollomed.net

ABOUT THE KECK SCHOOL OF MEDICINE OF USC

Founded in 1885, the Keck School of Medicine of USC is among the nation's leaders in innovative patient care, scientific discovery, education, and community service. It is part of Keck Medicine of USC, the University of Southern California's medical enterprise, one of only two university-owned academic medical centers in the Los Angeles area. This includes the Keck Medical Center of USC, composed of the Keck Hospital of USC and the USC Norris Cancer Hospital. The two world-class, USC-owned hospitals are staffed by more than 500 physicians who are faculty at the Keck School. The school today has more than 1,500 full-time faculty members and voluntary faculty of more than 2,400 physicians. These faculty direct the education of approximately 700 medical students and 1,000 students pursuing graduate and post-graduate degrees. The school trains more than 900 resident physicians in more than 50 specialty or subspecialty programs and is the largest educator of physicians practicing in Southern California. Together, the school's faculty and residents serve more than 1.5 million patients each year at Keck Hospital of USC and USC Norris Cancer Hospital, as well as USC-affiliated hospitals Children's Hospital Los Angeles and Los Angeles County + USC Medical Center. Keck School faculty also conduct research and teach at several research centers and institutes, including the USC Norris Comprehensive Cancer Center, the Zilkha Neurogenetic Institute, the Eli and Edythe Broad Center for Stem Cell Research and Regenerative Medicine at USC, the USC Cardiovascular Thoracic Institute, the USC Eye Institute and the USC Institute of Urology.

Forward Looking Statements
This press release may contain forward-looking statements, including information about management's view of Apollo Medical Holdings, Inc. ("the Company") future expectations, plans and prospects. In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this press release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. Some factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2014, under the caption "Risk Factors", which is on file with the Securities and Exchange Commission and available in the "Investor" section of the Company's website under the heading "SEC Filings". The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by Apollo Medical Holdings, Inc.

FOR MORE INFORMATION, PLEASE CONTACT:

Michael Sullivan
RedChip Companies Inc.
1-800-733-2447 Ext. 115
[email protected]

SOURCE Apollo Medical Holdings, Inc.